{"id":"W4210778581","doi":"10.1016/j.amjmed.2021.12.019","title":"Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations","year":2022,"lang":"en","type":"editorial","venue":"The American Journal of Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Duke Clinical Research Institute; National Institutes of Health; Biotronik; McMaster University; Takeda Pharmaceuticals U.S.A.; University of Wisconsin-Madison; Novartis; Sanofi; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Pfizer; Roche; Astellas Pharma US; AstraZeneca","keywords":"Medicine; Adjunct; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Vaccination; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Monoclonal antibody; Coronavirus Infections; Pandemic; Antibody; Immunology; Outbreak; Internal medicine; Infectious disease (medical specialty); Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01381077,0.003920214,0.004934418,0.004195798,0.003696035,0.009365277,0.00413228,0.03345262,0.02236191],"category_scores_gemma":[0.04537229,0.002188289,0.004200428,0.001801904,0.002359718,0.00571663,0.002358845,0.03378176,0.01339831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004308506,"about_ca_system_score_gemma":0.005117634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002871788,"about_ca_topic_score_gemma":0.008347545,"domain_scores_codex":[0.9901266,0.002053477,0.001384742,0.0008666521,0.004791209,0.0007773975],"domain_scores_gemma":[0.95315,0.01888863,0.004332615,0.0009816524,0.0154561,0.007191007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005211191,0.00001993154,0.00003779695,0.0001907406,0.00002412922,0.00009025727,0.00001071076,0.00001785795,0.00004819996,0.000150192,0.992906,0.006452212],"study_design_scores_gemma":[0.0002558185,0.00008203171,0.0004077419,0.0008857756,0.0001422382,0.000199332,0.00006849608,0.0001407788,0.00008344081,0.0006899381,0.9970115,0.00003288535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00005543171,0.005226036,0.0001150915,0.08579765,0.9060556,0.00004035301,0.00007803576,0.00007319729,0.00255865],"genre_scores_gemma":[0.0002973206,0.004203373,0.0001457679,0.06314208,0.9263499,0.00003725946,0.00005270692,0.00003253227,0.005739119],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.03345262,"threshold_uncertainty_score":0.074808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06582486288112625,"score_gpt":0.4479792901515489,"score_spread":0.3821544272704226,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}